Codexis is a biotechnology company that engineers enzymes for pharmaceutical, fine chemicals, flavors & fragrances, agrochemicals and more. Codexis engineers custom enzymes and microorganisms, which are sometimes referred to as biocatalysts. The Company's Codexis' proprietary technology called CodeEvolver is directed evolution technology based on the concept that natural genetic mutation and selection can be accelerated in the research laboratory to obtain specific improvements in the function of single proteins and multiprotein pathways. CodeEvolver combines DNA shuffling and bioinformatics with systems biology to create new biocatalysts.


Company Growth (employees)
Type
Public
HQ
Redwood City, US
Founded
2002
Size (employees)
106 (est)
Codexis was founded in 2002 and is headquartered in Redwood City, US

Key People/Management at Codexis

John Nicols

John Nicols

President & CEO
James Lalonde

James Lalonde

Senior Vice President, Research & Development

Codexis Office Locations

Codexis has an office in Redwood City
Redwood City, US (HQ)
200 Penobscot Dr

Codexis Financials and Metrics

Codexis Financials

Codexis's revenue was reported to be $48.8 m in FY, 2016
USD

Revenue (Q2, 2017)

10.3 m

Gross profit (Q2, 2017)

6.6 m

Gross profit margin (Q2, 2017), %

63%

Net income (Q2, 2017)

(6.3 m)

EBIT (Q2, 2017)

(6.3 m)

Market capitalization (13-Dec-2017)

368.3 m

Cash (30-Jun-2017)

28.8 m
Codexis's current market capitalization is $368.3 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

31.9 m35.3 m41.8 m48.8 m

Revenue growth, %

11%18%17%

Cost of goods sold

9.8 m

Gross profit

39.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

3.9 m7.1 m6.6 m7.5 m6.8 m6 m17.4 m8 m16 m14.9 m8 m10.3 m

Cost of goods sold

3 m3.8 m

Gross profit

5 m6.6 m

Gross profit Margin, %

62%63%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

22.1 m26.5 m23.3 m19.2 m

Inventories

1.5 m1.4 m992 k825 k

Current Assets

35.8 m33 m32.8 m27.2 m

PP&E

8.4 m4 m3.1 m2.2 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

26.9 m23.2 m20.1 m21.5 m22.2 m16.6 m17 m22.2 m22.4 m14.9 m13.9 m28.8 m

Inventories

2.1 m2 m2 m1.9 m992 k968 k678 k1 m1.2 m1.1 m1.1 m806 k

Current Assets

36.6 m34.2 m26.9 m28.2 m27.6 m21.4 m32.3 m28.8 m27.9 m30.1 m21.7 m40.4 m

PP&E

13.8 m7.4 m4.9 m4.4 m3.5 m3.2 m2.8 m2.8 m2.4 m2.3 m2.8 m3 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(41.3 m)(19.1 m)(7.6 m)(8.6 m)

Accounts Receivable

1.6 m1.6 m(3.5 m)1.4 m

Inventories

(185 k)92 k403 k167 k

Accounts Payable

308 k713 k(1.3 m)942 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(9.3 m)(6.4 m)(8.5 m)(4.6 m)(5.6 m)(10.9 m)(5.5 m)(7 m)(4.7 m)(3.3 m)(7.5 m)(13.7 m)

Accounts Receivable

1.1 m(9.7 m)3 m4 m(4.6 m)543 k(1.9 m)

Inventories

2 m992 k968 k678 k1 m1.2 m(84 k)(299 k)

Accounts Payable

3.3 m2.5 m2 m(3 m)(3.5 m)(395 k)(492 k)(1 m)(882 k)(446 k)
Y, 2017

Financial Leverage

1.6 x
Show all financial metrics

Codexis Market Value History

Codexis's Web-traffic and Trends

Codexis Online and Social Media Presence

Codexis Company Life and Culture

You may also be interested in